{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:05:42Z","timestamp":1761102342804},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11886-018-1058-8","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T04:32:27Z","timestamp":1536726747000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcatheter Mitral Valve Therapy: Defining the Patient Who Will Benefit"],"prefix":"10.1007","volume":"20","author":[{"given":"Marvin H.","family":"Eng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee Dee","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"1058_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005\u201311.","journal-title":"Lancet"},{"key":"1058_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","volume":"391","author":"V Dziadzko","year":"2018","unstructured":"Dziadzko V, Clavel M-A, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391:960\u20139.","journal-title":"Lancet"},{"key":"1058_CR3","doi-asserted-by":"crossref","unstructured":"Monteagudo Ruiz JM, Galderisi M, Buonauro A, et al. Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip). Eur Heart J Cardiovasc Imaging 2018:jey011-jey.","DOI":"10.1093\/ehjci\/jey011"},{"key":"1058_CR4","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jacc.2017.02.045","volume":"69","author":"A Regueiro","year":"2017","unstructured":"Regueiro A, Granada JF, Dagenais F, Rod\u00e9s-Cabau J. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69:2175\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/eurheartj\/ehv123","volume":"36","author":"F Maisano","year":"2015","unstructured":"Maisano F, Alfieri O, Banai S, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36:1651\u20139.","journal-title":"Eur Heart J"},{"key":"1058_CR6","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1161\/01.CIR.96.6.1819","volume":"96","author":"LH Ling","year":"1997","unstructured":"Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. Circulation. 1997;96:1819\u201325.","journal-title":"Circulation"},{"key":"1058_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.semtcvs.2014.07.004","volume":"26","author":"RM Suri","year":"2014","unstructured":"Suri RM, Schaff HV, Enriquez-Sarano M. Mitral valve repair in asymptomatic patients with severe mitral regurgitation: pushing past the tipping point. Semin Thorac Cardiovasc Surg. 2014;26:95\u2013101.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"1058_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jtcvs.2011.08.030","volume":"142","author":"Mehrdad Ghoreishi","year":"2011","unstructured":"Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing of surgery. J Thorac Cardiovasc Surg. 142:1439\u201352.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"1058_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65:1231\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0002-9149(96)00481-X","volume":"78","author":"DS Bach","year":"1996","unstructured":"Bach DS, Bolling SF. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol. 1996;78:966\u20139.","journal-title":"Am J Cardiol"},{"key":"1058_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","volume":"45","author":"AH Wu","year":"2005","unstructured":"Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJMoa1512913","volume":"374","author":"D Goldstein","year":"2016","unstructured":"Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344\u201353.","journal-title":"N Engl J Med"},{"key":"1058_CR13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675\u201380.","journal-title":"Heart"},{"key":"1058_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1540-8191.2011.01274.x","volume":"26","author":"E Marchena de","year":"2011","unstructured":"de Marchena E, Badiye A, Robalino G, et al. Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development. J Card Surg. 2011;26:385\u201392.","journal-title":"J Card Surg"},{"key":"1058_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.amjcard.2015.10.044","volume":"117","author":"C Giannini","year":"2016","unstructured":"Giannini C, Fiorelli F, De Carlo M, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol. 2016;117:271\u20137.","journal-title":"Am J Cardiol"},{"key":"1058_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.amjcard.2015.04.025","volume":"116","author":"F D'Ascenzo","year":"2015","unstructured":"D'Ascenzo F, Moretti C, Marra WG, et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol. 2015;116:325\u201331.","journal-title":"Am J Cardiol"},{"key":"1058_CR17","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1161\/CIR.0000000000000029","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129:2440\u201392.","journal-title":"Circulation"},{"key":"1058_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/ccd.26460","volume":"88","author":"L Azzalini","year":"2016","unstructured":"Azzalini L, Millan X, Khan R, et al. Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients undergoing transcatheter mitral valve repair. Catheter Cardiovasc Interv. 2016;88:1124\u201333.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1058_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","volume":"37","author":"M Puls","year":"2016","unstructured":"Puls M, Lubos E, Boekstegers P, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37:703\u201312.","journal-title":"Eur Heart J"},{"key":"1058_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/eurjhf\/hft021","volume":"15","author":"V Rudolph","year":"2013","unstructured":"Rudolph V, Lubos E, Schluter M, et al. Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients. Eur J Heart Fail. 2013;15:796\u2013807.","journal-title":"Eur J Heart Fail"},{"key":"1058_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/1755-5922.12058","volume":"32","author":"I Bozdag-Turan","year":"2014","unstructured":"Bozdag-Turan I, Paranskaya L, Birkemeyer R, et al. Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-Centre experience. Cardiovasc Ther. 2014;32:66\u201373.","journal-title":"Cardiovasc Ther"},{"key":"1058_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.910","volume":"20","author":"NA Geis","year":"2018","unstructured":"Geis NA, Puls M, Lubos E, et al. Safety and efficacy of MitraClip therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018;20:598\u2013608.","journal-title":"Eur J Heart Fail"},{"key":"1058_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.amjcard.2015.05.048","volume":"116","author":"H Lesevic","year":"2015","unstructured":"Lesevic H, Sonne C, Braun D, et al. Acute and midterm outcome after MitraClip therapy in patients with severe mitral regurgitation and left ventricular dysfunction. Am J Cardiol. 2015;116:749\u201356.","journal-title":"Am J Cardiol"},{"key":"1058_CR24","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.amjcard.2014.03.015","volume":"113","author":"G Melisurgo","year":"2014","unstructured":"Melisurgo G, Ajello S, Pappalardo F, et al. Afterload mismatch after MitraClip insertion for functional mitral regurgitation. Am J Cardiol. 2014;113:1844\u201350.","journal-title":"Am J Cardiol"},{"key":"1058_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jjcc.2015.05.015","volume":"67","author":"T Schau","year":"2016","unstructured":"Schau T, Isotani A, Neuss M, et al. Long-term survival after MitraClip<sup>&#xae;<\/sup> therapy in patients with severe mitral regurgitation and severe congestive heart failure: A comparison among survivals predicted by heart failure models. J Cardiol. 2016;67:287\u201394.","journal-title":"J Cardiol"},{"key":"1058_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jtcvs.2013.08.073","volume":"148","author":"R Varghese","year":"2014","unstructured":"Varghese R, Itagaki S, Anyanwu AC, Milla F, Adams DH. Predicting early left ventricular dysfunction after mitral valve&#xa0;reconstruction: The effect of atrial fibrillation and pulmonary hypertension. J Thorac Cardiovasc Surg. 2014;148:422\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1058_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/icvts\/ivu294","volume":"19","author":"J Wang","year":"2014","unstructured":"Wang J, Han J, Li Y, et al. Preoperative risk factors of medium-term mitral valve repair outcome. Interact Cardiovasc Thorac Surg. 2014;19:946\u201354.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1058_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5761\/atcs.oa.13-00364","volume":"21","author":"T Murashita","year":"2015","unstructured":"Murashita T, Okada Y, Kanemitsu H, et al. The impact of preoperative and postoperative pulmonary hypertension on long-term surgical outcome after mitral valve repair for degenerative mitral regurgitation. Ann Thorac Cardiovasc Surg. 2015;21:53\u20138.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1058_CR29","doi-asserted-by":"publisher","first-page":"e1817","DOI":"10.4244\/EIJ-D-16-00909","volume":"12","author":"E Yzeiraj","year":"2017","unstructured":"Yzeiraj E, Bijuklic K, Tiburtius C, et al. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. EuroIntervention. 2017;12:e1817\u2013e24.","journal-title":"EuroIntervention"},{"key":"1058_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ejhf.864","volume":"20","author":"E Tigges","year":"2018","unstructured":"Tigges E, Blankenberg S, von Bardeleben RS, et al. Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018;20:585\u201394.","journal-title":"Eur J Heart Fail"},{"key":"1058_CR31","first-page":"475","volume":"25","author":"S Barth","year":"2016","unstructured":"Barth S, Hautmann MB, Kerber S, et al. Hemodynamic improvement at three months after MitraClipA(R) treatment in end-stage heart failure patients with functional mitral regurgitation. J Heart Valve Dis. 2016;25:475\u201382.","journal-title":"J Heart Valve Dis"},{"key":"1058_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ahj.2007.03.033","volume":"154","author":"FL Dini","year":"2007","unstructured":"Dini FL, Conti U, Fontanive P, et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J. 2007;154:172\u20139.","journal-title":"Am Heart J"},{"key":"1058_CR33","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jacc.2017.09.015","volume":"70","author":"P Sorajja","year":"2017","unstructured":"\u2022\u2022 Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with Transcatheter mitral valve repair in the United States: an STS\/ACC TVT registry report. J Am Coll Cardiol. 2017;70:2315\u201327. This publication provides the most contemporary data regarding transcatheter mitral valve repair.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.amjcard.2017.05.044","volume":"120","author":"K Toyama","year":"2017","unstructured":"Toyama K, Ayabe K, Kar S, et al. Postprocedural changes of tricuspid regurgitation after MitraClip therapy for mitral regurgitation. Am J Cardiol. 2017;120:857\u201361.","journal-title":"Am J Cardiol"},{"key":"1058_CR35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/ehjci\/jeu114","volume":"15","author":"Y Ohno","year":"2014","unstructured":"Ohno Y, Attizzani GF, Capodanno D, et al. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip system: 30-day and 12-month follow-up from the GRASP registry. Eur Heart J Cardiovasc Imaging. 2014;15:1246\u201355.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1058_CR36","doi-asserted-by":"publisher","first-page":"e1680","DOI":"10.4244\/EIJV11I14A320","volume":"11","author":"AH Frangieh","year":"2016","unstructured":"Frangieh AH, Gruner C, Mikulicic F, et al. Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation. EuroIntervention. 2016;11:e1680\u2013e6.","journal-title":"EuroIntervention"},{"key":"1058_CR37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.amjcard.2016.10.049","volume":"119","author":"M Pighi","year":"2017","unstructured":"Pighi M, Estevez-Loureiro R, Maisano F, et al. Immediate and 12-month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 pilot sentinel registry of percutaneous edge-to-edge mitral valve repair of the European Society of Cardiology). Am J Cardiol. 2017;119:630\u20137.","journal-title":"Am J Cardiol"},{"key":"1058_CR38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609\u201320.","journal-title":"N Engl J Med"},{"key":"1058_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/CIRCULATIONAHA.108.841437","volume":"121","author":"DH Lee","year":"2010","unstructured":"Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010;121:973\u20138.","journal-title":"Circulation"},{"key":"1058_CR40","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jcin.2017.07.042","volume":"10","author":"C Metze","year":"2017","unstructured":"Metze C, Matzik A-S, Scherner M, et al. Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair. J Am Coll Cardiol Intv. 2017;10:1920\u20139.","journal-title":"J Am Coll Cardiol Intv"},{"key":"1058_CR41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.amjcard.2016.06.036","volume":"118","author":"U Schafer","year":"2016","unstructured":"Schafer U, Maisano F, Butter C, et al. Impact of Preprocedural left ventricular ejection fraction on 1-year outcomes after MitraClip implantation (from the ACCESS-EU phase I, a prospective, multicenter, nonrandomized Postapproval study of the MitraClip therapy in Europe). Am J Cardiol. 2016;118:873\u201380.","journal-title":"Am J Cardiol"},{"key":"1058_CR42","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395\u2013406.","journal-title":"N Engl J Med"},{"key":"1058_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(17)31600-8","volume":"390","author":"F Praz","year":"2017","unstructured":"Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017;390:773\u201380.","journal-title":"Lancet"},{"key":"1058_CR44","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.amjcard.2016.12.027","volume":"119","author":"H Lesevic","year":"2017","unstructured":"Lesevic H, Karl M, Braun D, et al. Long-term outcomes after MitraClip implantation according to the presence or absence of EVEREST inclusion criteria. Am J Cardiol. 2017;119:1255\u201361.","journal-title":"Am J Cardiol"},{"key":"1058_CR45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jcin.2016.12.280","volume":"10","author":"M Neuss","year":"2017","unstructured":"Neuss M, Schau T, Isotani A, Pilz M, Sch\u00f6pp M, Butter C. Elevated mitral valve pressure gradient after MitraClip implantation deteriorates long-term outcome in patients with severe mitral regurgitation and severe heart failure. J Am Coll Cardiol Intv. 2017;10:931\u20139.","journal-title":"J Am Coll Cardiol Intv"},{"key":"1058_CR46","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.amjcard.2017.07.027","volume":"120","author":"R Cheng","year":"2017","unstructured":"Cheng R, Dawkins S, Tat E, et al. Relation of residual mitral regurgitation despite elevated mitral gradients to risk of heart failure hospitalization after MitraClip repair. Am J Cardiol. 2017;120:1595\u2013600.","journal-title":"Am J Cardiol"},{"key":"1058_CR47","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/eurjhf\/hfs076","volume":"14","author":"T Siminiak","year":"2012","unstructured":"Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail. 2012;14:931\u20138.","journal-title":"Eur J Heart Fail"},{"key":"1058_CR48","doi-asserted-by":"publisher","first-page":"e000411","DOI":"10.1136\/openhrt-2016-000411","volume":"3","author":"J Lipiecki","year":"2016","unstructured":"Lipiecki J, Siminiak T, Sievert H, et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. Open Heart. 2016;3:e000411.","journal-title":"Open Heart"},{"key":"1058_CR49","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.106.677880","volume":"115","author":"LF Tops","year":"2007","unstructured":"Tops LF, Van de Veire NR, Schuijf JD, et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation. 2007;115:1426\u201332.","journal-title":"Circulation"},{"key":"1058_CR50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jacc.2009.03.071","volume":"54","author":"J-H Kim","year":"2009","unstructured":"Kim J-H, Kocaturk O, Ozturk C, et al. Mitral cerclage Annuloplasty, a novel Transcatheter treatment for secondary mitral valve regurgitation: initial results in swine. J Am Coll Cardiol. 2009;54:638\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jcin.2016.07.005","volume":"9","author":"G Nickenig","year":"2016","unstructured":"Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter mitral Annuloplasty in chronic functional mitral regurgitation: 6-month results with the Cardioband percutaneous mitral repair system. J Am Coll Cardiol Intv. 2016;9:2039\u201347.","journal-title":"J Am Coll Cardiol Intv"},{"key":"1058_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2016.10.068","volume":"69","author":"DWM Muller","year":"2017","unstructured":"Muller DWM, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69:381\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR53","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","volume":"131","author":"EH Blackstone","year":"2015","unstructured":"Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015;131:1989\u20132000.","journal-title":"Circulation"},{"key":"1058_CR54","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jacc.2015.08.881","volume":"66","author":"HB Ribeiro","year":"2015","unstructured":"Ribeiro HB, Nombela-Franco L, Munoz-Garcia AJ, et al. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry. J Am Coll Cardiol. 2015;66:2075\u201388.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR55","doi-asserted-by":"crossref","unstructured":"\u2022 Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv 2017. Seminal work first describing the a minimum residual left ventricular outflow tract area before left ventricular outflow obstruction occurs..","DOI":"10.1002\/ccd.27447"},{"key":"1058_CR56","doi-asserted-by":"crossref","unstructured":"Greenbaum AB, Condado JF, Eng M, et al. Long or redundant leaflet complicating transcatheter mitral valve replacement: case vignettes that advocate for removal or reduction of the anterior mitral leaflet. Catheter Cardiovasc Interv 2017.","DOI":"10.1002\/ccd.27054"},{"key":"1058_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jcin.2017.01.035","volume":"10","author":"VC Babaliaros","year":"2017","unstructured":"Babaliaros VC, Greenbaum AB, Khan JM, et al. Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during Transcatheter mitral valve replacement: first-in-human experience. JACC Cardiovasc Interv. 2017;10:798\u2013809.","journal-title":"JACC Cardiovasc Interv"},{"key":"1058_CR58","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/ccd.26975","volume":"90","author":"M Guerrero","year":"2017","unstructured":"Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv. 2017;90:1220\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1058_CR59","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jacc.2013.01.058","volume":"61","author":"A Cheung","year":"2013","unstructured":"Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1058_CR60","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.jcin.2015.08.012","volume":"8","author":"J Ye","year":"2015","unstructured":"Ye J, Cheung A, Yamashita M, et al. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv. 2015;8:1735\u201344.","journal-title":"JACC Cardiovasc Interv"},{"key":"1058_CR61","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.jtcvs.2014.10.075","volume":"149","author":"B Whisenant","year":"2015","unstructured":"Whisenant B, Jones K, Miller D, Horton S, Miner E. Thrombosis following mitral and tricuspid valve-in-valve replacement. J Thorac Cardiovasc Surg. 2015;149:e26\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1058_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ccd.26909","volume":"90","author":"MH Eng","year":"2017","unstructured":"Eng MH, Greenbaum A, Wang DD, et al. Thrombotic valvular dysfunction with transcatheter mitral interventions for postsurgical failures. Catheter Cardiovasc Interv. 2017;90:321\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1058_CR63","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.amjcard.2013.06.014","volume":"112","author":"A Butnaru","year":"2013","unstructured":"Butnaru A, Shaheen J, Tzivoni D, Tauber R, Bitran D, Silberman S. Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol. 2013;112:1439\u201344.","journal-title":"Am J Cardiol"},{"key":"1058_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.amjcard.2017.09.027","volume":"121","author":"MI Korber","year":"2018","unstructured":"Korber MI, Silwedel J, Friedrichs K, et al. Bleeding complications after percutaneous mitral valve repair with the MitraClip. Am J Cardiol. 2018;121:94\u20139.","journal-title":"Am J Cardiol"},{"key":"1058_CR65","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/icvts\/ivx043","volume":"24","author":"R Ben-Avi","year":"2017","unstructured":"Ben-Avi R, Orlov B, Sternik L, et al. Short- and long-term results after prosthetic mitral valve implantation in patients with severe mitral annulus calcification. Interact Cardiovasc Thorac Surg. 2017;24:876\u201381.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1058_CR66","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jacc.2018.02.054","volume":"71","author":"M Guerrero","year":"2018","unstructured":"Guerrero M, Urena M, Himbert D, et al. 1-year outcomes of Transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841\u201353.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-1058-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:26:16Z","timestamp":1568229976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-1058-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-1058-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"12 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Marvin H. Eng is a proctor for Edwards Lifesciences. Dee Dee Wang is a co-inventor of 3D-imaging software for anatomic analysis in structural heart procedures assigned to Henry Ford Hospital Health System. Dr. Wang also reports consultancy with Edwards Lifesciences and Materialize.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"107"}}